Skip to content

The American Consumer Institute

FacebooktwitterlinkedinrssvimeoFacebooktwitterlinkedinrssvimeo
Newsletter Sign Up ✉
VISIT : TheLostEconomy.com
  • Home
  • About Us
    • Experts
  • Blog
  • Issues
    • Technology
    • Consumer Tips / Health
    • Internet Public Policy Issues
    • ENERGY / Environment
    • Finance / Insurance
    • Taxation
  • News
  • Podcast
  • Events
  • Donate
  • Contact

Coalition Letter To Senate: Increase Drug Competition

Posted on June 7, 2018June 7, 2018 by editor

Today, forty-five organizations sent a letter to the US Senate calling for an end to the anticompetitive abuses that block competitive market entry by generic drug makers, which work to keep drug prices higher.  A copy of the letter is available here.

 

 

 

 

Further Reading

  • Greed, then Vigorous Competition for Patent Drug Makers
  • Generics and Biosimilars are the Keys to Lower Drug Prices
  • ACI Sends a Letter to Congress on Reducing Patient Drug Prices
  • Want Lower Drug Costs? Increase Generic Competition
  • Study Links PBMs to Medicine Overpayments
  • ACI Files Comments with the FTC Regarding PBM Business Practices and their Impact on Drug Prices
FacebooktwitterredditlinkedinFacebooktwitterredditlinkedin
Posted in Blog, Consumer Tips / Health, Health, IssuesTagged creates act, drug competition, drug prices, generics

Post navigation

ACI in the Morning Consult: Banning Silicone Would Cripple Transportation Industry
The Tortuous Path to Winning TimeWarner, Sky and Fox

THE AMERICAN CONSUMER INSTITUTE

:

CENTER FOR CITIZEN RESEARCH · COPYRIGHT © 2022

Privacy Policy | Terms of Use
  • Home
  • About Us
    • Experts
  • Blog
  • Issues
    • Technology
    • Consumer Tips / Health
    • Internet Public Policy Issues
    • ENERGY / Environment
    • Finance / Insurance
    • Taxation
  • News
  • Podcast
  • Events
  • Donate
  • Contact